WallStSmart

Mondelez International Inc (MDLZ)vsUnilever PLC ADR (UL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Unilever PLC ADR generates 31% more annual revenue ($50.50B vs $38.54B). UL leads profitability with a 18.8% profit margin vs 6.4%. MDLZ appears more attractively valued with a PEG of 1.66. MDLZ earns a higher WallStSmart Score of 51/100 (C-).

MDLZ

Buy

51

out of 100

Grade: C-

Growth: 4.7Profit: 5.5Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.60

UL

Buy

50

out of 100

Grade: C-

Growth: 2.0Profit: 8.5Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLZSignificantly Overvalued (-378.4%)

Margin of Safety

-378.4%

Fair Value

$12.85

Current Price

$57.18

$44.33 premium

UndervaluedFair: $12.85Overvalued
ULSignificantly Overvalued (-268.2%)

Margin of Safety

-268.2%

Fair Value

$20.26

Current Price

$60.65

$40.39 premium

UndervaluedFair: $20.26Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLZ3 strengths · Avg: 8.3/10
Market CapQuality
$73.78B9/10

Large-cap with strong market position

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$2.00B8/10

Generating 2.0B in free cash flow

UL4 strengths · Avg: 8.8/10
Return on EquityProfitability
31.0%10/10

Every $100 of equity generates 31 in profit

Market CapQuality
$132.46B9/10

Large-cap with strong market position

Operating MarginProfitability
20.1%8/10

Strong operational efficiency at 20.1%

Free Cash FlowQuality
$5.48B8/10

Generating 5.5B in free cash flow

Areas to Watch

MDLZ4 concerns · Avg: 3.8/10
PEG RatioValuation
1.664/10

Expensive relative to growth rate

P/E RatioValuation
30.3x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.604/10

Distress zone — elevated risk

Profit MarginProfitability
6.4%3/10

6.4% margin — thin

UL3 concerns · Avg: 2.7/10
PEG RatioValuation
1.914/10

Expensive relative to growth rate

Revenue GrowthGrowth
-3.2%2/10

Revenue declined 3.2%

EPS GrowthGrowth
-3.4%2/10

Earnings declined 3.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLZ

The strongest argument for MDLZ centers on Market Cap, Price/Book, Free Cash Flow.

Bull Case : UL

The strongest argument for UL centers on Return on Equity, Market Cap, Operating Margin. Profitability is solid with margins at 18.8% and operating margin at 20.1%.

Bear Case : MDLZ

The primary concerns for MDLZ are PEG Ratio, P/E Ratio, Altman Z-Score.

Bear Case : UL

The primary concerns for UL are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

MDLZ profiles as a value stock while UL is a declining play — different risk/reward profiles.

MDLZ carries more volatility with a beta of 0.37 — expect wider price swings.

MDLZ is growing revenue faster at 9.3% — sustainability is the question.

UL generates stronger free cash flow (5.5B), providing more financial flexibility.

Bottom Line

MDLZ scores higher overall (51/100 vs 50/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Mondelez International Inc

CONSUMER DEFENSIVE · CONFECTIONERS · USA

Mondelez International, Inc. is an American multinational confectionery, food, holding and beverage and snack food company based in Chicago, Illinois.

Visit Website →

Unilever PLC ADR

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Unilever PLC is a fast moving consumer goods company in Asia, Africa, the Middle East, Turkey, Russia, Ukraine, Belarus, America and Europe. The company is headquartered in London, the United Kingdom.

Want to dig deeper into these stocks?